Sulzer earnings call: margins up, orders delayed

Sulzer AG ((CH:SUN)) has held its Q2 earnings call. Read on for the main highlights of the call.

Sulzer’s latest earnings call painted a cautiously positive picture, with management highlighting broad-based margin expansion and solid operational execution despite softer orders. Investors heard a story of Flow and Services regaining momentum and the Sulzer Excellence program lifting profitability, even as Chemtech struggles, cash generation is under pressure and large projects are pushed into the second half.

Profitability Improvement

Group profitability clearly improved in the first half as the EBITDA margin rose to 15.5%, an increase of about 110 basis points versus last year’s reporting basis. Higher gross margins, supported by tighter execution under the Sulzer Excellence program, lifted absolute EBITDA and net income in Swiss francs, underscoring that the company is managing its cost base effectively.

Flow Division Margin Momentum

The Flow division emerged as a standout, with its EBITDA margin climbing to 13.3% from 8.7% in the prior-year period, a roughly 100 basis point gain versus comparable reporting. After a weak start with Q1 order intake down 3.8%, Flow returned to growth in Q2 with orders up 6.6%, signaling renewed demand and better pricing discipline.

Services Growth and Margin Expansion

Services continued to show resilience, delivering 4.4% sales growth in the first half despite already strong comparables in the prior year. The unit also expanded its order-intake gross margin by 140 basis points to 40.6% and lifted its EBITDA margin by about 100 basis points, even as regional disruptions weighed on parts of the portfolio.

Book-to-Bill and Backlog Health

Order dynamics remained supportive overall, with book-to-bill ratios above 1.0 across business units except for new technologies within Chemtech. Management emphasized that the order pipeline is filling again and flagged early signs that large orders are returning, although most of these awards are expected to land in the back half of the year, particularly in the fourth quarter.

Sulzer Excellence Delivering Operational Gains

The Sulzer Excellence program continues to be a key profitability driver, improving on-time and in-spec delivery while tightening commercial discipline through market-value pricing and shorter order cycles. Supply-chain optimization and design-to-cost measures have also contributed to higher margins, indicating that operational gains are structural rather than purely cyclical.

Confirmed Full-Year Guidance

Despite the uneven order intake in the first half, Sulzer reiterated its 2026 full-year targets of 1% to 5% order growth, 2% to 5% sales growth and an EBITDA margin of roughly 16.5%. The company acknowledged that orders will be skewed toward the second half, particularly Q4, and that Q3 will likely remain muted, but management sees enough visibility in the backlog and pipeline to keep guidance unchanged.

FX and Currency Management

Foreign-exchange volatility weighed on reported figures, with currency movements shaving about CHF 100 million off sales and orders, equating to roughly a 5% FX impact. Even so, Sulzer’s margin gains and Excellence-driven efficiencies more than offset these headwinds in Swiss-franc terms, helping protect overall profitability.

Innovation and New Solutions

On the innovation front, Sulzer highlighted progress on advanced projects such as subsea CO2 reinjection pumps developed with Petrobras and Technip, which showcase its engineering capabilities in emerging decarbonization markets. The company is also pushing ahead with PEF polymer trials as a potential PET replacement, pointing to longer-term growth optionality even if commercialization timelines remain uncertain.

Group Order Intake Decline

Headline orders were down 3.9% in the first half, reflecting a combination of delayed awards and missed large projects rather than broad-based weakness. Management stressed that the shortfall amounted to less than CHF 80 million in absolute terms and expects much of this to be recovered as large contracts are decided later in the year.

Chemtech Severe Headwinds

Chemtech remained the main drag, with order intake plunging 22.7% and sales down 4.9% in the first half amid significant project delays. New technologies in areas like biopolymers, carbon capture and sustainable aviation fuel saw slower decision-making, driving a 3.6 percentage point drop in Chemtech’s order-intake gross margin from 35.9% to 32.3%.

MTCS and New Technologies Weakness

Within Chemtech, MTCS and other new-technology activities posted notably weaker trends, with reported sales down around 18%. While order intake in Chemtech improved from a 27.7% decline in Q1 to a 16.1% decline in Q2, the division remains under volume and margin pressure, underscoring how dependent it is on securing large, often lumpy, project awards.

Higher Net Working Capital and Cash Impact

Balance-sheet metrics showed some strain as net working capital rose by approximately CHF 100 million to CHF 117 million year-on-year, lifting the ratio to 26% of sales from 22%. This increase, combined with fewer large down payments, reduced free cash flow by around CHF 40 million, reminding investors that Sulzer’s cash conversion is sensitive to project phasing.

Project Delays from Geopolitical Disruption

Geopolitical tensions and supply-chain issues, including disruptions linked to the Middle East and routes such as the Strait of Hormuz, delayed several large projects and repair activities. These factors weighed on order intake and affected industry and fertilizer-related business in both the Flow division and Services, adding another layer of uncertainty to near-term volumes.

Restructuring and One-offs in Chemtech

To address Chemtech’s structural challenges, Sulzer accelerated restructuring with an additional roughly 10% personnel reduction in the division implemented around June and July. The company also booked an impairment of about CHF 8 million related to an R&D center in Singapore and flagged further low single-digit million restructuring charges for the second half.

Order Intake Margin and Large Order Volatility

Group order-intake margin slipped to 35.7%, a decline of 60 basis points year-on-year, mainly due to missing high-margin PLA projects that had boosted last year’s figures by about CHF 65 million. This underscores the volatility that large, specialized orders can introduce to Sulzer’s margin profile, even as the underlying run-rate business remains stable.

Service Repair Delays

Within Services, the repair segment, which represents roughly 20% of the unit, is seeing customers postpone maintenance cycles by several weeks or months amid a high fuel and pricing environment. These delays are tempering short-term growth, though management suggests that underlying demand is deferred rather than lost, potentially supporting a future catch-up.

Forward-Looking Guidance and Outlook

Looking ahead, Sulzer is standing by its full-year targets despite acknowledging that Q3 will be weak and that many large orders are likely to close in Q4. The combination of a healthy book-to-bill ratio, improving Flow and Services performance and ongoing Excellence gains provides a cushion, but the reliance on late-year awards and Chemtech’s recovery keeps execution risk firmly in focus for investors.

Sulzer’s earnings call leaves investors balancing robust margin momentum and solid execution against softer orders, Chemtech-specific challenges and elevated working capital. The company’s confidence in meeting 2026 guidance, plus a visible backlog and innovation pipeline, supports a constructive medium-term view, but share watchers will be watching the timing and scale of second-half orders closely.